Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001011438-17-000113
Filing Date
2017-02-13
Accepted
2017-02-13 16:28:21
Documents
1
Group Members
GEORGE SOROSROBERT SOROS

Document Format Files

Seq Description Document Type Size
1 form_sc13ga-abeona.htm SC 13G/A 137913
  Complete submission text file 0001011438-17-000113.txt   139774
Mailing Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219
Business Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 2149055100
ABEONA THERAPEUTICS INC. (Subject) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-33655 | Film No.: 17599560
SIC: 2834 Pharmaceutical Preparations

Mailing Address 250 WEST 55TH STREET, FLOOR 27 NEW YORK NY 10019
Business Address 250 WEST 55TH STREET, FLOOR 27 NEW YORK NY 10019 (212) 872-1054
SOROS FUND MANAGEMENT LLC (Filed by) CIK: 0001029160 (see all company filings)

EIN.: 133914976 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A